High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System
Molecules · 2025
DOI: 10.3390/molecules30081811 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Jiasong Chang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cellular Physiology, Shanxi Medical University, Ministry of Education, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, High-Throughput Screening Assays. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Basic Research Program of Shanxi Province, National Natural Science Foundation of China, NSFC.
Abstract (Originalsprache)
Genome editing is a promising therapeutic strategy for genetic disorders by modifying the genome precisely, especially the CRISPR/Cas9 system. However, a major limitation of CRISPR/Cas9 in gene therapy is the biosafety issues caused by off-target effects. Compounds that can modulate the genome editing efficiency of the CRISPR/Cas9 system, especially those reducing the off-target effects, are potentially useful pharmacological tools for improving the effectiveness and safety of genome editing. Here, we performed high-throughput screening in HEK 293FT cells to discover compounds that decrease or increase the genome editing efficiency of the CRISPR/Cas9 system from 9930 compounds. After two rounds of screening, we identified that CP-724714, a ErbB2 (HER2) tyrosine kinase inhibitor, decreased the CRISPR/Cas9 efficiency and reduced the off-target effects by suppressing the efficiency of CRISPR/Cas9, and was thus named a CRISPR decelerator (or inhibitor), while Clofarabine, a DNA synthesis inhibitor, increased the efficiency of CRISPR/Cas9, and was named a CRISPR accelerator. We further identified four compounds (Tranilast, Cerulenin, Rosolic acid and Resveratrol) that affected the efficiency of single-strand annealing (SSA) repair. Among them, Tranilast, Cerulenin and Rosolic acid are potential SSA decelerators, while Resveratrol is a potential SSA accelerator. These identified compounds may be useful in optimizing mammalian genetic manipulation techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Cellular Physiology, Shanxi Medical University, Ministry of Education, Taiyuan 030001, China.
- Department of Physiology, Shanxi Medical University, Taiyuan 030001, China.
- Biological Science Research Center, Southwest University, Chongqing 400715, China.
- Department of Preschool Education, Lvliang Teachers College, Lvliang 033001, China.
ORCID-Profile: Jiasong Chang, Tong Zhang, Zhangrong Jia
Förderung
- Applied Basic Research Program of Shanxi Province
- National Natural Science Foundation of China
- NSFC
Zitieren
APA
Chang, J., Yang, X., Zhang, T., Sun, H., Cheng, H., Jia, Z., Li, Y., Ma, S., Sun, T., & Cao, J. (2025). High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System. Molecules. https://doi.org/10.3390/molecules30081811
Vancouver
Chang J, Yang X, Zhang T, Sun H, Cheng H, Jia Z, et al. High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System. Molecules. 2025. doi:10.3390/molecules30081811
BibTeX
@article{Chang2025,
author = {Chang, Jiasong and Yang, Xiulong and Zhang, Tong and Sun, Hao and Cheng, Hongying and Jia, Zhangrong and Li, Yiying and Ma, Sanyuan and Sun, Teng and Cao, Jimin},
title = {High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30081811}
}
EUVIMED